Holger J Schünemann Selected Research

Holger J Schünemann Research Topics

Disease

22	Neoplasms (Cancer) 10/2022 - 11/2002
18	Hemorrhage 01/2022 - 09/2004
9	Asthma (Bronchial Asthma) 12/2019 - 09/2004
8	Hypersensitivity (Allergy) 10/2022 - 09/2004
8	Venous Thromboembolism 01/2022 - 09/2004
7	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2002
7	Infections 01/2020 - 01/2007
5	Allergic Rhinitis 10/2022 - 09/2010
5	COVID-19 01/2022 - 01/2020
5	Thrombosis (Thrombus) 10/2021 - 09/2004
5	Thrombocytopenia (Thrombopenia) 01/2020 - 06/2008
4	Critical Illness (Critically Ill) 10/2021 - 04/2008
4	Venous Thrombosis (Deep-Vein Thrombosis) 04/2015 - 04/2008
4	Gastroesophageal Reflux (GERD) 01/2009 - 11/2004
4	Chronic Obstructive Pulmonary Disease (COPD) 07/2008 - 09/2006
3	Stroke (Strokes) 09/2021 - 10/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2021 - 03/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2006
3	Tuberculosis (Tuberculoses) 01/2019 - 01/2012
3	Atrial Fibrillation 12/2015 - 09/2004
3	Human Influenza (Influenza) 09/2013 - 06/2011
3	Prostatic Neoplasms (Prostate Cancer) 10/2009 - 12/2004
2	Milk Hypersensitivity (Milk Allergy) 04/2022 - 12/2010
2	Embolism (Embolus) 09/2021 - 09/2004
2	Anemia 01/2020 - 09/2006
2	Obesity 01/2020 - 10/2016
2	Wounds and Injuries (Trauma) 12/2019 - 11/2018
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2008 - 04/2008
2	Dyspnea (Shortness of Breath) 09/2004 - 10/2003
1	Bone Diseases (Bone Disease) 10/2022
1	Noncommunicable Diseases 09/2021
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Asymptomatic Infections 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Autism Spectrum Disorder 04/2020
1	Peptic Ulcer (Peptic Ulcers) 01/2020
1	Leukocytosis (Pleocytosis) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Thrombophilia 01/2020
1	Fever (Fevers) 01/2020
1	Edema (Dropsy) 01/2020
1	Thrombocytosis (Thrombocythemia) 01/2020
1	Paresis (Hemiparesis) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Tachycardia (Tachyarrhythmias) 01/2020

Drug/Important Bio-Agent (IBA)

11	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 04/2008
10	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 04/2008
8	AnticoagulantsIBA 01/2022 - 04/2008
7	Pharmaceutical PreparationsIBA 10/2022 - 11/2005
6	AllergensIBA 01/2020 - 09/2010
5	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 09/2004
5	Hormones (Hormone)IBA 01/2021 - 11/2002
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2019 - 09/2004
3	Antiviral Agents (Antivirals)IBA 10/2021 - 04/2012
3	VaccinesIBA 01/2021 - 11/2011
3	Warfarin (Coumadin)FDA LinkGeneric 12/2015 - 04/2008
3	Esomeprazole (Nexium)FDA Link 01/2007 - 11/2004
2	Immunoglobulin E (IgE)IBA 04/2022 - 04/2011
2	Thioguanine (Tioguanine)FDA Link 01/2021 - 10/2006
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 09/2006
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 10/2016
2	CalciumIBA 01/2017 - 02/2005
2	Vitamin D FDA LinkGeneric 01/2017 - 01/2016
2	Estrogens (Estrogen)FDA Link 01/2017 - 10/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2011 - 08/2009
2	Proteins (Proteins, Gene)FDA Link 12/2010 - 05/2008
2	6-sulfatoxymelatoninIBA 03/2010 - 06/2008
2	MelatoninIBA 03/2010 - 06/2008
2	Formoterol Fumarate (Oxis)FDA Link 11/2008 - 09/2006
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2008 - 09/2004
2	Vitamin K FDA Link 07/2008 - 06/2008
2	ximelagatran (Exanta)IBA 07/2008 - 06/2008
2	Fondaparinux (Arixtra)FDA Link 06/2008 - 05/2008
2	Insulin-Like Growth Factor I (IGF-1)IBA 07/2005 - 11/2002
2	Proton Pump InhibitorsIBA 01/2005 - 11/2004
2	Glucose (Dextrose)FDA LinkGeneric 01/2005 - 11/2002
1	Local Anti-Infective Agents (Antiseptics)IBA 10/2022
1	EnzymesIBA 10/2022
1	azelastine (Optivar)FDA LinkGeneric 10/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 10/2022
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2020
1	C-Reactive ProteinIBA 01/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020

Therapy/Procedure

17	Therapeutics 10/2021 - 11/2002
6	Drug Therapy (Chemotherapy) 10/2022 - 01/2016
4	Immunotherapy 04/2022 - 09/2010
4	Central Venous Catheters 01/2020 - 04/2008
3	Artificial Respiration (Mechanical Ventilation) 01/2020 - 04/2008
2	Thrombolytic Therapy 01/2020 - 09/2004
2	Aftercare (After-Treatment) 01/2007 - 01/2005
2	Chemoprevention 01/2007 - 02/2005
1	Adjuvant Chemotherapy 01/2021
1	Patient Readmission 01/2020
1	Mechanical Ventilators (Ventilator) 01/2020
1	Noninvasive Ventilation 01/2020